Guideline for proprietary names for medicines

This document provides guidance to applicants regarding the acceptability of proposed proprietary names of products submitted for registration as medicines. It represents the current thinking of the South African Health Products Regulatory Authority [SAHPRA] on naming policy, how naming policy is intended to inform treatment choice, promote health and protect the public in the safe and effective use of medicines, and how it contributes to the safety, quality and efficacy of medicines prescribing, dispensing, administration and usage by health care professionals and the public of South Africa. It is not intended to be an exhaustive listing and elaboration of all of the factors considered during the registration process of the relative weighting attached to any such factor.